BioSpace News Archive

ADC Therapeutics SA announced today that Chris Martin, Chief Executive Officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30th at 9:20 a.m. ET.

Iovance Biotherapeutics, Inc. today reported that the Iovance Cell Therapy Center ( i CTC ) successfully manufactured and delivered the first clinical batch of TIL cell therapy LN-145.

Stealth BioTherapeutics Corp announced today the presentation of new promising data from a study evaluating the effects of SBT-272 in a murine model of Parkinson’s disease (PD).

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced that its management team will give a corporate presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference.

Novan, Inc., announced the comprehensive safety data readout as part of the Company’s B-SIMPLE4 pivotal Phase 3 study of SB206 for the treatment of molluscum contagiosum.

Daré Bioscience, Inc. today announced the initiation of a Phase 1/2 clinical study of DARE-VVA1, a novel intravaginal tamoxifen product being developed for the treatment of moderate to severe vulvar and vaginal atrophy (VVA).

Boundless Bio today announced that Chief Executive Officer, Zachary Hornby, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021, from 1:20-1:50 p.m. ET.

OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that the Biomedical Advanced Research Development Authority (BARDA), will provide up to $13.6 million in funding for the Company to obtain 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for OraSure’s InteliSwab™ COVID-19 rapid test from the Food and Drug Administration (FDA).

UroGen Pharma Ltd. today announced that it will present at the Cantor Fitzgerald 2021 Virtual Global Healthcare Conference on Thursday, September 30, 2021, at 3:20 p.m. Eastern Time.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.